Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C59H92O4 |
| Molecular Weight | 865.3594 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 9 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C(O)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(C)=C1O
InChI
InChIKey=QNTNKSLOFHEFPK-UPTCCGCDSA-N
InChI=1S/C59H92O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42,60-61H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+
| Molecular Formula | C59H92O4 |
| Molecular Weight | 865.3594 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 9 |
| Optical Activity | NONE |
UBIQUINOL is a reduced form of coenzyme Q10, a lipid-soluble molecule that consists of an aromatic ring and a 10-unit isoprenoid chain. It is naturally produced by the body. A significant increase in plasma CoQ10 status observed after supplementation in one study suggested that UBIQUINOL is a better supplemental form to enhance the CoQ10 status than ubiquinone (the oxidized form of Q10). UBIQUINOL has also been found to reduce oxidative stress induced by strenuous exercise. Oxidative stress is associated with aging and many chronic diseases, such as cardiovascular diseases, cancers, and cognitive decline. Ubiquinol has furthermore been shown to improve mitochondrial oxidative metabolism in the brain, and cognitive improvement was found as a result of Ubiquinol intake in chronic fatigue syndrome patients. UBIQUINOL is considered safe, but can have side effects such as upper abdominal pain, loss of appetite, nausea, diarrhea and headaches. CoQ10 might make blood-thinning drugs, such as warfarin (Coumadin, Jantoven), less effective. This could increase the risk of a blood clot.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:50:47 GMT 2025
by
admin
on
Mon Mar 31 20:50:47 GMT 2025
|
| Record UNII |
M9NL0C577Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/16/1765
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
179403
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB32843
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
9962735
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
C026663
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
M9NL0C577Y
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
UBIQUINOL
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
1705334
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
DB11340
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
64183
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
M9NL0C577Y
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
17976
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
100000125973
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
DTXSID90912840
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | |||
|
39085
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY | RxNorm | ||
|
992-78-9
Created by
admin on Mon Mar 31 20:50:47 GMT 2025 , Edited by admin on Mon Mar 31 20:50:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |